Exact Mass: 531.0630552

Exact Mass Matches: 531.0630552

Found 37 metabolites which its exact mass value is equals to given mass value 531.0630552, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

SCHEMBL12732971

CDP-4-dehydro-3,6-dideoxy-alpha-D-glucose

C15H23N3O14P2 (531.0655238)

dTDP-3-amino-3,4,6-trideoxy-D-glucose

dTDP-3-amino-3,4,6-trideoxy-D-glucose; dTDP-3-amino-3,4,6-trideoxy-alpha-D-glucose

C16H27N3O13P2 (531.1019072)

dTDP-beta-L-daunosamine

dTDP-β-L-daunosamine

C16H27N3O13P2 (531.1019072)

A dTDP-sugar having beta-L-daunosamine as the sugar component.

dTDP-4-methylamino-2,4-dideoxy-beta-L-xylose

dTDP-4-methylamino-2,4-dideoxy-beta-L-xylose

C16H27N3O13P2 (531.1019072)

dTDP-L-ristosamine

dTDP-L-ristosamine

C16H27N3O13P2 (531.1019072)

dTDP-2,6-dideoxy-D-kanosamine

dTDP-2,6-dideoxy-D-kanosamine

C16H27N3O13P2 (531.1019072)

CDP-4-dehydro-3,6-dideoxy-D-glucose epimer

CDP-4-dehydro-3,6-dideoxy-D-glucose epimer

C15H23N3O14P2 (531.0655238)

N5-(cytidine 5-diphosphoramidyl)-L-glutamine

N5-(cytidine 5-diphosphoramidyl)-L-glutamine

C14H23N5O13P2 (531.0767568)

Cobimetinib

1-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzoyl}-3-(piperidin-2-yl)azetidin-3-ol

C21H21F3IN3O2 (531.0630552)

dragmacidin D

dragmacidin D

C25H22BrN7O2 (531.1018252)

herdmanine E

herdmanine E

C22H22BrN5O6 (531.0753372)

I-SAP

(Z)-[3S-[1alpha,2alpha,3beta,5alpha]]-7-[3-[[(4-iodophenyl)sulfonyl]amino]-6,6-dimethylbicyclo[3.1.1]hept-2-yl]-5-heptenoic acid

C22H30INO4S (531.094021)

Cobimetinib

Cobimetinib

C21H21F3IN3O2 (531.0630552)

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EE - Mitogen-activated protein kinase (mek) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor

3-(7-Bromo-9,9-dimethyl-9H-fluoren-2-yl)-9-(4-fluorophenyl)-9H-carbazole

3-(7-Bromo-9,9-dimethyl-9H-fluoren-2-yl)-9-(4-fluorophenyl)-9H-carbazole

C33H23BrFN (531.099779)

(6R,7R)-3-[(4-Carbamoylpyridin-1-ium-1-yl)methyl]-8-oxo-7-[[(2R)-2-phenyl-2-sulfoacetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

(6R,7R)-3-[(4-Carbamoylpyridin-1-ium-1-yl)methyl]-8-oxo-7-[[(2R)-2-phenyl-2-sulfoacetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

C22H19N4O8S2- (531.0644274)

CP-547632

3-((4-Bromo-2,6-difluorobenzyl)oxy)-5-(3-(4-(pyrrolidin-1-yl)butyl)ureido)isothiazole-4-carboxamide

C20H24BrF2N5O3S (531.0751198)

C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor

Cobimetinib (R-enantiomer)

Cobimetinib (R-enantiomer)

C21H21F3IN3O2 (531.0630552)

ADENOSINE 3-PHOSPHATE 5-PHOSPHOSULFATE, TETRALITHIUM SALT

ADENOSINE 3-PHOSPHATE 5-PHOSPHOSULFATE, TETRALITHIUM SALT

C10H11Li4N5O13P2S (531.0189536)

dTDP-3-amino-3,4,6-trideoxy-alpha-D-glucose

dTDP-3-amino-3,4,6-trideoxy-alpha-D-glucose

C16H27N3O13P2 (531.1019072)

Cobimetinib (racemate)

Cobimetinib (racemate)

C21H21F3IN3O2 (531.0630552)

CDP-4-dehydro-3,6-dideoxy-D-glucose

CDP-4-dehydro-3,6-dideoxy-D-glucose

C15H23N3O14P2 (531.0655238)

CDP-3,6-dideoxy-alpha-D-glucose(2-)

CDP-3,6-dideoxy-alpha-D-glucose(2-)

C15H23N3O14P2-2 (531.0655238)

CDP-3,6-dideoxy-alpha-D-mannose(2-)

CDP-3,6-dideoxy-alpha-D-mannose(2-)

C15H23N3O14P2-2 (531.0655238)

CDP-alpha-D-abequose(2-)

CDP-alpha-D-abequose(2-)

C15H23N3O14P2-2 (531.0655238)

[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl] phosphate

[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl] phosphate

C15H23N3O14P2-2 (531.0655238)

3-(guanosine-5-diphospho)-D-glycerate

3-(guanosine-5-diphospho)-D-glycerate

C13H19N5O14P2 (531.0403734)

(2R)-2-hydroxy-3-[hydroxy-[(2R,3S,4S)-2,3,4-trihydroxy-5-(2,4,8-trioxo-1H-pyrimido[4,5-b]quinolin-10-yl)pentoxy]phosphoryl]oxypropanoic acid

(2R)-2-hydroxy-3-[hydroxy-[(2R,3S,4S)-2,3,4-trihydroxy-5-(2,4,8-trioxo-1H-pyrimido[4,5-b]quinolin-10-yl)pentoxy]phosphoryl]oxypropanoic acid

C19H22N3O13P (531.0890212)

CDP-abequose(2-)

CDP-abequose(2-)

C15H23N3O14P2-2 (531.0655238)

CDP-3,6-dideoxy-D-mannose(2-)

CDP-3,6-dideoxy-D-mannose(2-)

C15H23N3O14P2-2 (531.0655238)

CDP-3,6-dideoxy-D-glucose(2-)

CDP-3,6-dideoxy-D-glucose(2-)

C15H23N3O14P2-2 (531.0655238)

2-[({3-[3,4-Dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)benzoyloxy]-4,5-dihydroxyphenyl}(hydroxy)methylidene)amino]acetic acid

2-[({3-[3,4-Dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)benzoyloxy]-4,5-dihydroxyphenyl}(hydroxy)methylidene)amino]acetic acid

C23H17NO14 (531.0649022)

CDP-4-dehydro-3,6-dideoxy-alpha-D-glucose

CDP-4-dehydro-3,6-dideoxy-alpha-D-glucose

C15H23N3O14P2 (531.0655238)

3-(D-Glyceryl)-diphospho-5'-guanosine

3-(D-Glyceryl)-diphospho-5'-guanosine

C13H19N5O14P2 (531.0403734)

3PG-factor 420-0

3PG-factor 420-0

C19H22N3O13P (531.0890212)

CDP-4-dehydro-3,6-dideoxy-glucose

CDP-4-dehydro-3,6-dideoxy-glucose

C15H23N3O14P2 (531.0655238)

6-{4-[1-(2-amino-2,3-dihydro-1h-imidazol-4-yl)ethyl]-7-hydroxy-1h-indol-3-yl}-3-(6-bromo-1h-indol-3-yl)-1h-pyrazin-2-one

6-{4-[1-(2-amino-2,3-dihydro-1h-imidazol-4-yl)ethyl]-7-hydroxy-1h-indol-3-yl}-3-(6-bromo-1h-indol-3-yl)-1h-pyrazin-2-one

C25H22BrN7O2 (531.1018252)

6-{4-[(1s)-1-[(2s)-2-amino-2,3-dihydro-1h-imidazol-4-yl]ethyl]-7-hydroxy-1h-indol-3-yl}-3-(6-bromo-1h-indol-3-yl)-1h-pyrazin-2-one

6-{4-[(1s)-1-[(2s)-2-amino-2,3-dihydro-1h-imidazol-4-yl]ethyl]-7-hydroxy-1h-indol-3-yl}-3-(6-bromo-1h-indol-3-yl)-1h-pyrazin-2-one

C25H22BrN7O2 (531.1018252)